Pulmonary function abnormalities in systemic lupus erythematosus responsive to glucocorticoid therapy

Area of Science:

• Pulmonary Medicine
• Rheumatology
• Critical Care Medicine

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
• Pulmonary involvement in SLE can range from interstitial lung disease to pleuritis and respiratory muscle weakness.
• Ventilatory defects, both restrictive and obstructive, are recognized but less commonly detailed complications of SLE.

Observation:

• A patient diagnosed with systemic lupus erythematosus presented with significant respiratory compromise.
• The patient exhibited a combination of moderately severe restrictive and obstructive ventilatory defects.
• Pulmonary function tests were crucial in quantifying the severity and nature of the respiratory impairment.

Findings:

• Treatment with corticosteroids led to a notable improvement in the patient's respiratory status.
• Specifically, the obstructive component of the ventilatory defect showed gradual amelioration and ultimately resolved.
• Gas exchange parameters demonstrated progressive enhancement throughout a four-year period of continuous steroid therapy.

Implications:

• Corticosteroids may be an effective therapeutic option for managing pulmonary complications in systemic lupus erythematosus.
• Early recognition and management of ventilatory defects in SLE patients are essential for improving outcomes.
• This case highlights the potential reversibility of obstructive lung disease in SLE with appropriate immunosuppressive treatment.